Profil Anemia pada Pasien Chronic Kidney Disease di Rumah Sakit Universitas Sebelas Maret
DOI:
https://doi.org/10.20961/plexus.v4i6.2531Keywords:
anemia, hemoglobin, normositik normokromik, profil anemia, Penyakit Ginjal KronikAbstract
Pendahuluan: Anemia adalah komplikasi umum pada pasien Chronic Kidney Disease (CKD), terutama pada stadium lanjut, yang disebabkan oleh penurunan produksi eritropoietin dan inflamasi kronik. Identifikasi profil anemia pada CKD sangat penting untuk merancang strategi penanganan yang efektif dan mencegah komplikasi lebih lanjut. Penelitian ini diharapkan dapat memberikan wawasan baru mengenai profil anemia pada pasien CKD di Rumah Sakit Universitas Sebelas Maret.
Metode: Penelitian ini menggunakan desain deskriptif cross sectional dengan teknik total sampling pada pasien rawat inap CKD di Rumah Sakit Universitas Sebelas Maret (RS UNS) selama tahun 2024. Data dikumpulkan dari rekam medis dan hasil laboratorium, lalu dianalisis secara deskriptif menggunakan SPSS.
Hasil: Dari 161 pasien CKD, mayoritas berusia ≥60 tahun (53,09%) dan berjenis kelamin laki-laki (57,76%). Stadium terbanyak adalah stadium 5 hemodialisis (37,89%). Rerata kadar hemoglobin (Hb) sebesar 9,51 ± 2,55 g/dL. Derajat anemia sedang paling banyak ditemukan (52,8%), diikuti anemia berat (23,6%), anemia ringan (13%), dan tidak anemia (10,6%). Jenis anemia terbanyak adalah anemia normositik normokromik (68,3%), disusul mikrositik hipokromik (21,1%), sedangkan anemia makrositik tidak ditemukan. Terdapat tren penurunan kadar Hb seiring peningkatan stadium CKD.
Kesimpulan: Anemia merupakan komplikasi yang umum terjadi pada pasien Chronic Kidney Disease (CKD) di RS UNS. Derajat anemia sedang merupakan bentuk yang paling banyak dijumpai, mengindikasikan adanya gangguan eritropoiesis yang signifikan namun belum mencapai kondisi kritis. Selain itu, jenis anemia yang paling dominan adalah anemia normositik normokromik, dengan stadium terbanyak pada pasien adalah stadium 5 Hemodialisis (5HD).
References
Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
Alemu, B., Techane, T., Dinegde, N. G., & Tsige, Y. (2021). Prevalence of anemia and its associated factors among chronic kidney disease patients attending selected public hospitals of Addis Ababa, Ethiopia: Institutional-based cross-sectional study. International Journal of Nephrology and Renovascular Disease, 14, 67–75. https://doi.org/10.2147/IJNRD.S296995
Alagoz, S., Dincer, M. T., Eren, N., et al. (2020). Prevalence of anemia in predialysis chronic kidney disease: Is the study center a significant factor? PLoS ONE, 15(4), e0230980. https://doi.org/10.1371/journal.pone.0230980
Badura, K., Janc, J., Wąsik, J., Gnitecki, S., Skwira, S., Młynarska, E., et al. (2024). Anemia of Chronic Kidney Disease—A Narrative Review of Its Pathophysiology, Diagnosis, and Management. Biomedicines, 12(6), 1191. https://doi.org/10.3390/biomedicines12061191
Brar, S., & Mrkell, M. (2019). Anemia of chronic kidney disease. StatPearls. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/38927397
Fiseha, T., Gebreweld, A., & Ebrahim, H. (2021). Prevalence and associate factors of anemia among chronic kidney disease patients in sub-Saharan Africa: A cross-sectional study. BMC Nephrology, 22(1), 23. https://doi.org/10.1186/s12882-021-02219-0
Gluszak, C., de Vries-Brilland, M., Seegers, V., Baroin, C., Kieffer, H., Delva, R., et al. (2022). Impact of iron-deficiency management on quality of life in patients with cancer: A prospective cohort study (Camara Study). The Oncologist, 27(4), 328–333. https://doi.org/10.1093/oncolo/oyac005
Guppy, M., et al. (2024). Rate of decline in kidney function with age: a systematic review. BMJ Open, 14(11), e089783. https://doi.org/10.1136/bmjopen-2024-089783
Hain, D., et al. (2023). Iron-deficiency anemia in CKD: A narrative review for the kidney care team. Kidney Medicine, 5(8), 100677. https://doi.org/10.1016/j.xkme.2023.100677
Idris, I., et al. (2018). Anaemia among primary care patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD): A multicentred cross-sectional study. BMJ Open, 8(12), e025125. https://doi.org/10.1136/bmjopen-2018-025125
Ihme. (2023). The Lancet: New study reveals global anemia cases remain persistently high among women and children. Anemia rates decline for men. 31 Juli 2023, 8–11.
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., et al. (2019). Chronic kidney disease: Global dimension and perspectives. The Lancet, 382(9888), 260–272. https://doi.org/10.1016/S0140-6736(13)60687-X
Kujovich, J. L. (2016). Evaluation of anemia. Obstetrics and Gynecology Clinics of North America, 43(2), 247–264. https://doi.org/10.1016/j.ogc.2016.01.009
Kurniawan, P., Rotty, L., & Palar, S. (2015). Gambaran status besi pada pasien penyakit ginjal kronik yang menjalani hemodialisis. https://doi.org/10.35790/ecl.v2i2.5049
Leone, A., et al. (2019). Food and food products on the Italian market for ketogenic dietary treatment of neurological diseases. Nutrients, 11(5), 1104. https://doi.org/10.3390/nu11051104
Minutolo, R., Grandaliano, G., Di Rienzo, P., et al. (2015). Prevalence, incidence, and treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: Findings from a retrospective real-world study in Italy. Journal of Nephrology, 28(2), 347–357. https://doi.org/10.1007/s40620-014-0115-0
Molla, A. M., et al. (2023). Prevalence and treatment patterns of anemia in individuals with chronic kidney disease across Asia: A systematic review and meta-analysis. Journal of Nephrology, 36(2), 347–357. https://doi.org/10.1007/s40620-022-01475-x
Ortiz, A., et al. (2023). Ageing meets kidney disease. Nephrology Dialysis Transplantation, 38(3), 523–526. https://doi.org/10.1093/ndt/gfac199
Portolés, J., Martín, L., Broseta, J. J., & Cases, A. (2021). Anemia in chronic kidney disease: From pathophysiology and current treatments, to future agents. Frontiers in Medicine, 8, 642296. https://doi.org/10.3389/fmed.2021.642296
Santos-Silva, A., et al. (2019). Hepcidin in chronic kidney disease anemia. Vitamins, 110, 243–264. https://doi.org/10.1016/j.bbamem.2019.02.012
Vikrant, S. (2019). Etiological spectrum of anemia in non-dialysis-dependent chronic kidney disease: A single-center study from India. Saudi Journal of Kidney Diseases and Transplantation, 30(4), 932–942. https://doi.org/10.4103/1319-2442.265471
Vohra, R., et al. (2022). Prevalence of anemia in predialysis chronic kidney disease patients. Diabetes Research and Clinical Practice, 171, 108543. https://doi.org/10.1016/j.diabres.2021.108543
Zhang, L., Zhao, M., Zuo, L., et al. (2016). China Kidney Disease Network (CK-NET) 2015 annual data report. Kidney International Supplements, 6(1), e1–e81. https://doi.org/10.1016/j.kisu.2016.03.002
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Rizki Amelia Faujiah, Evi Liliek Wulandari, Sigit Setyawan, Coana Sukmagautama
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright @2022. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
